LU82975A1 - 5-amino-(3,4'-bipyridine)-6(1h)-one-1'-oxide,sa preparation et son utilisation comme agent cardiotonique - Google Patents

5-amino-(3,4'-bipyridine)-6(1h)-one-1'-oxide,sa preparation et son utilisation comme agent cardiotonique Download PDF

Info

Publication number
LU82975A1
LU82975A1 LU82975A LU82975A LU82975A1 LU 82975 A1 LU82975 A1 LU 82975A1 LU 82975 A LU82975 A LU 82975A LU 82975 A LU82975 A LU 82975A LU 82975 A1 LU82975 A1 LU 82975A1
Authority
LU
Luxembourg
Prior art keywords
amino
acid
oxide
bipyridine
preparation
Prior art date
Application number
LU82975A
Other languages
English (en)
French (fr)
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of LU82975A1 publication Critical patent/LU82975A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/22Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU82975A 1979-12-03 1980-12-03 5-amino-(3,4'-bipyridine)-6(1h)-one-1'-oxide,sa preparation et son utilisation comme agent cardiotonique LU82975A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9950379A 1979-12-03 1979-12-03
US9950379 1979-12-03

Publications (1)

Publication Number Publication Date
LU82975A1 true LU82975A1 (fr) 1981-07-23

Family

ID=22275318

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82975A LU82975A1 (fr) 1979-12-03 1980-12-03 5-amino-(3,4'-bipyridine)-6(1h)-one-1'-oxide,sa preparation et son utilisation comme agent cardiotonique

Country Status (18)

Country Link
JP (1) JPS56103165A (sv)
KR (1) KR830004247A (sv)
AU (1) AU6472280A (sv)
BE (1) BE886437A (sv)
DE (1) DE3045637A1 (sv)
DK (1) DK513180A (sv)
ES (1) ES497345A0 (sv)
FI (1) FI803738L (sv)
FR (1) FR2471982A1 (sv)
GB (1) GB2064533A (sv)
IL (1) IL61537A0 (sv)
IT (1) IT8026375A0 (sv)
LU (1) LU82975A1 (sv)
NL (1) NL8006511A (sv)
NO (1) NO803595L (sv)
PT (1) PT72122B (sv)
SE (1) SE8008456L (sv)
ZA (1) ZA807431B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD298781A5 (de) * 1990-03-09 1992-03-12 Inst Wirkstofforschung Verfahren zur herstellung von 5,4'-bipyridin-1'-oxiden
JP2008524233A (ja) 2004-12-16 2008-07-10 バーテックス ファーマシューティカルズ インコーポレイテッド 炎症性疾患、増殖性疾患および免疫介在性疾患の治療のためのtecファミリータンパク質キナーゼのインヒビターとして有用なピリド−2−オン

Also Published As

Publication number Publication date
DK513180A (da) 1981-06-04
ZA807431B (en) 1981-11-25
IL61537A0 (en) 1980-12-31
SE8008456L (sv) 1981-06-04
KR830004247A (ko) 1983-07-09
AU6472280A (en) 1981-06-11
NO803595L (no) 1981-06-04
FI803738L (fi) 1981-06-04
PT72122B (en) 1981-09-29
ES8200346A1 (es) 1981-10-16
DE3045637A1 (de) 1981-08-27
NL8006511A (nl) 1981-07-01
PT72122A (en) 1980-12-01
BE886437A (fr) 1981-06-02
FR2471982A1 (fr) 1981-06-26
ES497345A0 (es) 1981-10-16
IT8026375A0 (it) 1980-12-02
GB2064533A (en) 1981-06-17
JPS56103165A (en) 1981-08-18

Similar Documents

Publication Publication Date Title
CH620908A5 (sv)
KR0164842B1 (ko) 신규 벤즈옥사진, 벤조티아진 유도체 및 그 제조방법
LU83259A1 (fr) Imidazopyridines,leur preparation et leur utilisation comme agents cardiotiniques
JPS61500494A (ja) 5―ヘテロアリールイミダゾール―2―オン類
BE1000573A4 (fr) Derives de 1-(hydroxystyryl)-5h-2,3-benzodiazepine, procede pour les preparer et compositions pharmaceutiques les contenant.
FR2464264A1 (fr) 6-(pyridinyl)-3(2h)pyridazinones, leur preparation et leur utilisation therapeutique
DE69917074T2 (de) Optisch aktives pyridyl-4h-1,2,4-oxadiazinderivat und seine verwendung zur behandlung von gefässkrankheiten
LU82975A1 (fr) 5-amino-(3,4'-bipyridine)-6(1h)-one-1'-oxide,sa preparation et son utilisation comme agent cardiotonique
LU82650A1 (fr) 3-(hydroxy ou hydroxymethyl)-5-(4-pyridinyl)-2(1h)-pyridinones,leur preparation et leur utilisation comme agents cardiotoniques
HU191753B (en) Process for preparing 5-acyl-2-/1h/-pyridinine deriva-tives
LU83214A1 (fr) Derives de pyrazolopyridine,leur preparation et leur utilisation comme agents cardiotoniques
LU83032A1 (fr) 3-acylamino-5(pyridinyl)-2(1h)-pyridinones,leur preparation et leur utilisation comme agents cardiotoniques
JPH01500596A (ja) ピリドン‐ピリジル‐イミダゾリルおよびトリアゾリル化合物並びにそれらの強心薬としての使用
FR2496659A1 (fr) Derives de 1,2 dihydro-5(pyridinyl)nicotinamide, leur preparation et leur utilisation comme agents cardiotoniques et intermediaires
LU82997A1 (fr) 6-(pyridinyl)-pyridazines,leur preparation et leur utilisation therapeutique
WO2007085203A1 (en) New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease
LU83396A1 (fr) Compositions cardiotoniques contenant des aminophenylpyridines,nouvelles aminophenylpyridines et leur preparation
CN109988182B (zh) 银杏内酯b衍生物及其应用
BE884859A (fr) 6-(pyridinyl)-3 (2h)pyridazinones, leur preparation et leur utilisation therapeutique
DE3432062A1 (de) Pyrazoldionderivate und ihre anwendung bei der bekaempfung von krankheiten
JPS63130592A (ja) 過酸化脂質生成抑制剤
CN116874486A (zh) 氨基酸修饰的s,s-七环羧酸化学合成,抗栓活性和应用
BE898359A (fr) Compositions pharmaceutiques contenant un dérivé de l'acide aminobenzoique convenant notamment au traitement des thromboses.
LU83007A1 (fr) (phenyl substitue)pyridines,leur preparation et leur utilisation comme agents cardiotoniques
LU83169A1 (fr) Sels de n-(3-dimethylamino-2-(4-pyridinyl)-2-propenylidene)-n-methylmethaniminium,leur preparation et leur utilisation comme agents cardiotoniques et comme intermediaires